| --- | --- | --- | |-------------------------|-------|-------| | | | | | | | | | | | | | | | | | Q4 and YE '20 Financial | | | | March 2021 Presentation | | | | | | | Forward-Looking Statement This presentation contains forward-looking statements relating to, among other things, the commercial success of TAVALISSE in the U.S. and TAVLESSE in Europe; Rigel's ability to achieve development, regulatory and commercial milestone payments; as well as tiered royalties; Rigel's expected operating results for the y ...